Kenacort-A en es it fr

Category

Kenacort-A
add to favotites goo dig stu tec squ mys
fac del pro twi yah mya far


Kenacort-A Brand names, Kenacort-A Analogs

Kenacort-A Brand Names Mixture

  • Aristoform R Crm 0.1% (Clioquinol + Triamcinolone Acetonide)
  • Derma-4 Ont (Neomycin Sulfate + Nystatin + Thiostrepton (Antibiotic of a Streptomyces Species) + Triamcinolone Acetonide)
  • Kenacomb Cream (Gramicidin + Neomycin Sulfate + Nystatin + Triamcinolone Acetonide)
  • Kenacomb Mild Cream (Gramicidin + Neomycin Sulfate + Nystatin + Triamcinolone Acetonide)
  • Kenacomb Mild Ointment (Gramicidin + Neomycin Sulfate + Nystatin + Triamcinolone Acetonide)
  • Kenacomb Ointment (Gramicidin + Neomycin Sulfate + Nystatin + Triamcinolone Acetonide)
  • Kenacomb Ont (Gramicidin + Neomycin (Neomycin Sulfate) + Nystatin + Triamcinolone Acetonide)
  • Mecomb Crm 0.1% (Gramicidin + Neomycin (Neomycin Sulfate) + Nystatin + Triamcinolone Acetonide)
  • Oribiotic Ointment (Bacitracin + Lidocaine + Neomycin (Neomycin Sulfate) + Nystatin + Triamcinolone Acetonide)
  • Panolog Cream (Neomycin (Neomycin Sulfate) + Nystatin + Thiostrepton (Antibiotic of a Streptomyces Species) + Triamcinolone Acetonide)
  • Panolog Ointment (Neomycin (Neomycin Sulfate) + Nystatin + Thiostrepton (Antibiotic of a Streptomyces Species) + Triamcinolone Acetonide)
  • Ratio-Triacomb Regular Cream (Gramicidin + Neomycin (Neomycin Sulfate) + Nystatin + Triamcinolone Acetonide)
  • Solvaderm Ointment (Neomycin (Neomycin Sulfate) + Nystatin + Thiostrepton (Antibiotic of a Streptomyces Species) + Triamcinolone Acetonide)
  • Theraderm Cream (Gramicidin + Neomycin (Neomycin Sulfate) + Nystatin + Triamcinolone Acetonide)
  • Viaderm Kc Crm (Gramicidin + Neomycin (Neomycin Sulfate) + Nystatin + Triamcinolone Acetonide)
  • Viaderm Kc Ont (Gramicidin + Neomycin (Neomycin Sulfate) + Nystatin + Triamcinolone Acetonide)

Kenacort-A Chemical_Formula

C21H27FO6

Kenacort-A RX_link

http://www.rxlist.com/cgi/generic/triamaer.htm

Kenacort-A fda sheet

Kenacort-A FDA

Kenacort-A msds (material safety sheet)

Kenacort-A MSDS

Kenacort-A Synthesis Reference

Fried et al., J. Am. Chem.. Soc. 80, 2338 (1958)

Kenacort-A Molecular Weight

394.434 g/mol

Kenacort-A Melting Point

274 - 278 (dec) oC

Kenacort-A H2O Solubility

80 mg/L

Kenacort-A State

Solid

Kenacort-A LogP

0.329

Kenacort-A Dosage Forms

Cream; Liquid; Metered-dose (aerosol); Ointment; Paste; Suspension; Syrup; Tablet

Kenacort-A Indication

For the treatment of perennial and seasonal allergic rhinitis.

Kenacort-A Pharmacology

Triamcinolone and its derivatives are synthetic glucocorticoids that are used for their antiinflammatory or immunosuppressive properties.

Kenacort-A Absorption

Rapid absorption following oral administration

Kenacort-A side effects and Toxicity

LD50=>500mg/kg (in rats)

Kenacort-A Patient Information

Patients being treated with Azmacort Inhalation Aerosol should receive the following information and instructions. This information is intended to aid them in the safe and effective use of this medication. It is not a complete disclosure of all possible adverse or intended effects.

Patients should use Azmacort Inhalation Aerosol at regular intervals as directed. Results of clinical trials indicate that significant improvement in asthma may occur by 1 week, but maximum benefit may not be achieved for 2 weeks or more. The patient should not increase the prescribed dosage but should contact the physician if symptoms do not improve or if the condition worsens.

In clinical studies and post-marketing experience with Azmacort Inhalation Aerosol, local infections of the oropharynx with Candida albicans have occurred. When such an infection develops, it should be treated with appropriate local or systemic (i.e., oral antifungal) therapy while remaining on treatment with Azmacort Inhalation Aerosol. However, at times therapy with Azmacort Inhalation Aerosol may need to be interrupted.

Patients should be instructed to track their use of Azmacort Inhalation Aerosol and to dispose of the canister after 240 actuations since reliable dose delivery cannot be assured after 240 doses.

Patients who are on immunosuppressant doses of corticosteroids should be warned to avoid exposure to chickenpox or measles and if exposed, to obtain medical advice.

Kenacort-A Organisms Affected

Humans and other mammals